Royce & Associates LP increased its position in shares of Stevanato Group S.p.A. (NYSE:STVN – Free Report) by 45.8% during the third quarter, Holdings Channel reports. The institutional investor owned 343,159 shares of the company’s stock after purchasing an additional 107,869 shares during the quarter. Royce & Associates LP’s holdings in Stevanato Group were worth $6,863,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Russell Investments Group Ltd. lifted its position in Stevanato Group by 10.8% in the 1st quarter. Russell Investments Group Ltd. now owns 78,317 shares of the company’s stock valued at $2,514,000 after acquiring an additional 7,615 shares in the last quarter. Clearbridge Investments LLC lifted its position in Stevanato Group by 13.1% during the first quarter. Clearbridge Investments LLC now owns 1,729,397 shares of the company’s stock worth $55,514,000 after acquiring an additional 200,753 shares during the last quarter. Thornburg Investment Management Inc. increased its holdings in shares of Stevanato Group by 14.5% during the first quarter. Thornburg Investment Management Inc. now owns 196,840 shares of the company’s stock worth $6,319,000 after purchasing an additional 25,000 shares during the period. Bessemer Group Inc. increased its stake in Stevanato Group by 5.7% in the first quarter. Bessemer Group Inc. now owns 292,726 shares of the company’s stock valued at $9,396,000 after acquiring an additional 15,831 shares during the last quarter. Finally, Altitude Crest Partners Inc. bought a new position in Stevanato Group in the first quarter valued at approximately $17,655,000.
Wall Street Analysts Forecast Growth
Separately, Citigroup cut their target price on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th.
Stevanato Group Price Performance
NYSE:STVN opened at €19.00 ($20.00) on Monday. Stevanato Group S.p.A. has a one year low of €16.56 ($17.43) and a one year high of €34.73 ($36.56). The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The firm has a 50-day moving average of €19.56 and a 200-day moving average of €19.94.
Stevanato Group (NYSE:STVN – Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The company had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.16 earnings per share. As a group, analysts anticipate that Stevanato Group S.p.A. will post 0.5 earnings per share for the current fiscal year.
Stevanato Group Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
- Five stocks we like better than Stevanato Group
- What does consumer price index measure?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Are Penny Stocks a Good Fit for Your Portfolio?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding STVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stevanato Group S.p.A. (NYSE:STVN – Free Report).
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.